ABBV 2Q22 Mavyert sales=$398M, +5% QoQ: https://investors.abbvie.com/news-releases/news-release-details/abbvie-reports-second-quarter-2022-financial-results The geographic breakdown was: US $203M, +20% QoQ; ex-US $195M, -8% QoQ.